Insights from the 68th ASH Annual Meeting, an independent review of the ASH Annual Meeting, is a two-day program designed to provide the latest science and education from the world’s premier hematology event. The abstracts selected for presentation and discussion reflect the foremost research, insights, and advances in hematology that will impact clinical practice and patient care.

The program features in-depth discussions and analyses of the latest scientific findings in blood disorders and cancers, as well as practice-changing advances in treatment. Expert faculty will review the findings, discuss their potential impact on the current standard of care, and apply the results within the clinical context of a patient case.

Intended Learners
The educational activity is intended for hematologists/oncologists, medical oncologists, oncology NPs/PAs, pharmacists, nurses, and other healthcare professionals who treat patients with hematologic disorders.

Learning Objectives
After attending the Insights from the 68th ASH Annual Meeting, learners should be able to :

1. Review the latest data on the treatment of hematologic disorders

2. Identify recent clinical advances to optimize outcomes in patients with hematologic disorders

3. Discuss current challenges and controversies in the management of hematologic disorders

4. Assess the latest data on cellular therapies for the treatment of hematologic disorders

5. Apply best practices for the management of complex cases involving patients with hematologic disorders

REFUND POLICY

Refunds of 50% of the registration fee will be provided if you cancel up to 30 days before Insights from the 68th ASH Annual Meeting - Boston commences.  There are no refunds for cancellations within the 30-day window of the start of the event. To request a refund, please email [email protected]

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact [email protected] for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc). 

 Horizon CME will NOT provide international travelers with an invitation letter to attend this in-person activity. If you reside outside the United States or Canada and register and pay for this event, AND you are unable to obtain a visa to attend, no refund will be issued.

Presented By